241 related articles for article (PubMed ID: 20810616)
1. Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells.
Yamaguchi T; Reif GA; Calvet JP; Wallace DP
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F944-51. PubMed ID: 20810616
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.
Spirli C; Morell CM; Locatelli L; Okolicsanyi S; Ferrero C; Kim AK; Fabris L; Fiorotto R; Strazzabosco M
Hepatology; 2012 Dec; 56(6):2363-74. PubMed ID: 22653837
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.
Yamaguchi T; Nagao S; Wallace DP; Belibi FA; Cowley BD; Pelling JC; Grantham JJ
Kidney Int; 2003 Jun; 63(6):1983-94. PubMed ID: 12753285
[TBL] [Abstract][Full Text] [Related]
4. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease.
Nagao S; Yamaguchi T; Kusaka M; Maser RL; Takahashi H; Cowley BD; Grantham JJ
Kidney Int; 2003 Feb; 63(2):427-37. PubMed ID: 12631108
[TBL] [Abstract][Full Text] [Related]
5. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.
Yamaguchi T; Pelling JC; Ramaswamy NT; Eppler JW; Wallace DP; Nagao S; Rome LA; Sullivan LP; Grantham JJ
Kidney Int; 2000 Apr; 57(4):1460-71. PubMed ID: 10760082
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
Ambrosini G; Cheema HS; Seelman S; Teed A; Sambol EB; Singer S; Schwartz GK
Mol Cancer Ther; 2008 Apr; 7(4):890-6. PubMed ID: 18413802
[TBL] [Abstract][Full Text] [Related]
7. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.
Yamaguchi T; Hempson SJ; Reif GA; Hedge AM; Wallace DP
J Am Soc Nephrol; 2006 Jan; 17(1):178-87. PubMed ID: 16319189
[TBL] [Abstract][Full Text] [Related]
8. The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis.
Buchholz B; Klanke B; Schley G; Bollag G; Tsai J; Kroening S; Yoshihara D; Wallace DP; Kraenzlin B; Gretz N; Hirth P; Eckardt KU; Bernhardt WM
Nephrol Dial Transplant; 2011 Nov; 26(11):3458-65. PubMed ID: 21804086
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells.
Belibi FA; Reif G; Wallace DP; Yamaguchi T; Olsen L; Li H; Helmkamp GM; Grantham JJ
Kidney Int; 2004 Sep; 66(3):964-73. PubMed ID: 15327388
[TBL] [Abstract][Full Text] [Related]
10. Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation.
Nguyen AN; Jansson K; Sánchez G; Sharma M; Reif GA; Wallace DP; Blanco G
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F897-906. PubMed ID: 21697238
[TBL] [Abstract][Full Text] [Related]
11. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.
Yamaguchi T; Wallace DP; Magenheimer BS; Hempson SJ; Grantham JJ; Calvet JP
J Biol Chem; 2004 Sep; 279(39):40419-30. PubMed ID: 15263001
[TBL] [Abstract][Full Text] [Related]
12. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
[TBL] [Abstract][Full Text] [Related]
13. Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin.
Reif GA; Yamaguchi T; Nivens E; Fujiki H; Pinto CS; Wallace DP
Am J Physiol Renal Physiol; 2011 Nov; 301(5):F1005-13. PubMed ID: 21816754
[TBL] [Abstract][Full Text] [Related]
14. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways.
Jansson K; Nguyen AN; Magenheimer BS; Reif GA; Aramadhaka LR; Bello-Reuss E; Wallace DP; Calvet JP; Blanco G
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F982-90. PubMed ID: 22859406
[TBL] [Abstract][Full Text] [Related]
15. Activation of cytosolic phospholipase A2alpha by epidermal growth factor (EGF) and phorbol ester in HeLa cells: different effects of inhibitors for EGF receptor, protein kinase C, Src, and C-Raf.
Matsuzawa Y; Kiuchi Y; Toyomura K; Matsumoto I; Nakamura H; Fujino H; Murayama T; Kawashima T
J Pharmacol Sci; 2009 Oct; 111(2):182-92. PubMed ID: 19783865
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.
Pinto CS; Raman A; Reif GA; Magenheimer BS; White C; Calvet JP; Wallace DP
J Am Soc Nephrol; 2016 Apr; 27(4):1124-34. PubMed ID: 26289612
[TBL] [Abstract][Full Text] [Related]
17. Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease.
Parnell SC; Raman A; Zhang Y; Daniel EA; Dai Y; Khanna A; Reif GA; Vivian JL; Fields TA; Wallace DP
Kidney Int; 2022 Nov; 102(5):1103-1114. PubMed ID: 35760151
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway.
Peng CL; Guo W; Ji T; Ren T; Yang Y; Li DS; Qu HY; Li X; Tang S; Yan TQ; Tang XD
Cancer Biol Ther; 2009 Sep; 8(18):1729-36. PubMed ID: 19633425
[TBL] [Abstract][Full Text] [Related]
19. PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.
Gedaly R; Angulo P; Hundley J; Daily MF; Chen C; Koch A; Evers BM
Anticancer Res; 2010 Dec; 30(12):4951-8. PubMed ID: 21187475
[TBL] [Abstract][Full Text] [Related]
20. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.
Belibi FA; Wallace DP; Yamaguchi T; Christensen M; Reif G; Grantham JJ
J Am Soc Nephrol; 2002 Nov; 13(11):2723-9. PubMed ID: 12397042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]